お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
979721

OTC医薬品の世界市場:製品 (咳・風邪&インフルエンザ・鎮痛薬、皮膚科製品・ビタミン・ミネラル・サプリメント)・剤型・流通チャネル・地域別の予測・機会 (2025年)

Global Over the Counter Drugs Market, By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements, Other), By Dosage Form, By Distribution Channel, By Region, Forecast & Opportunities, 2025

出版日: | 発行: TechSci Research | ページ情報: 英文 112 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.84円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

OTC医薬品の世界市場:製品 (咳・風邪&インフルエンザ・鎮痛薬、皮膚科製品・ビタミン・ミネラル・サプリメント)・剤型・流通チャネル・地域別の予測・機会 (2025年)
出版日: 2021年01月01日
発行: TechSci Research
ページ情報: 英文 112 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界におけるOTC医薬品の市場規模は、2019年に1400億米ドルを上回り、予測期間中は約8.23%のCAGRで成長すると予測されています。世界のOTC医薬品市場は、世界中の人々の健康意識の高まりによって推進されています。さらに、OTC薬の購入は処方箋を必要としないため費用効果が高く、予測期間中の市場の成長にプラスの影響を与えると予想されます。これらの薬の入手可能性と手頃な価格は、市場でのOTC薬の採用率をさらに高めています。また、急速に拡大するヘルスケアおよび医薬品業界は、今後数年間で市場の成長をさらに強化することが期待されています。

当レポートでは、世界のOTC医薬品市場について調査し、各セグメントに基づいた分析と予測を提供しており、市場動向・競合状況の分析、および主要企業のプロファイルなどを提供しています。

目次

第1章 製品概要

第2章 調査手法

第3章 COVID-19が世界のOTC医薬品市場に与える影響

第4章 エグゼクティブサマリー

第5章 顧客の声

第6章 世界のOTC医薬品市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 製品別(咳、風邪&インフルエンザ、鎮痛薬、皮膚科製品、ビタミン、ミネラル、サプリメント(VMS)、その他)
    • 剤形別(錠剤、カプセル、粉末、軟膏、液体)
    • 流通チャネル別(病院薬局、小売薬局、オンライン薬局、その他)
    • 企業別
    • 地域別
  • 製品市場マップ

第7章 アジア太平洋のOTC医薬品市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 製品別
    • 剤型別
    • 流通チャネル別
    • 国別
  • アジア太平洋:国別分析
    • 中国
    • インド
    • オーストラリア
    • 日本
    • 韓国

第8章 欧州のOTC医薬品市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 製品別
    • 剤型別
    • 流通チャネル別
    • 国別
  • 欧州:国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 北米のOTC医薬品市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 製品別
    • 剤形別
    • 流通チャネル別
    • 国別
  • 北米:国別分析
    • 米国
    • メキシコ
    • カナダ

第10章 南米のOTC医薬品市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 製品別
    • 剤形別
    • 流通チャネル別
    • 国別
  • 南米:国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカのOTC医薬品市場の展望

  • 市場規模と予測
    • 金額ベース
  • 市場シェアと予測
    • 製品別
    • 剤形別
    • 流通チャネル別
    • 国別
  • 中東・アフリカ:国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向

第14章 競合情勢

  • 競合展望
  • 企業プロファイル
  • プロファイルされた主要企業
    • Johnson and Johnson
    • GlaxoSmithKline PLC (GSK Consumer Healthcare)
    • Perrigo Company PLC
    • Reckitt Benckiser Group PLC
    • Takeda Pharmaceutical Company Ltd
    • Roche Holding AG
    • The Procter & Gamble Company
    • Sanofi S.A
    • Gilead Sciences Inc.
    • Bayer Healthcare AG
    • AstraZeneca plc.
    • Alacer Corp.
    • Alcon Inc.

第15章 戦略的推奨事項

第16章 当社について&免責事項

図表

List of Figures

  • Figure 1: Global OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 2: Global OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 3: Global OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 4: Global OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 5: Global OTC Drugs Market Size, By Company (USD Million), 2015-2025F
  • Figure 6: Global OTC Drugs Market Size, By Region (USD Million), 2015-2025F
  • Figure 7: Global OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 8: North America OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 9: North America OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 10: North America OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 11: North America OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 12: North America OTC Drugs Market Size, By Country (USD Million), 2015-2025F
  • Figure 13: North America OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 14: North America OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 15: United States OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 16: United States OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 17: United States OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 18: United States OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 19: United States OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 20: Canada OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 21: Canada OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 22: Canada OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 23: Canada OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 24: Canada OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 25: Mexico OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 26: Mexico OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 27: Mexico OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 28: Mexico OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 29: Mexico OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 30: Europe OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 31: Europe OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 32: Europe OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 33: Europe OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 34: Europe OTC Drugs Market Size, By Country (USD Million), 2015-2025F
  • Figure 35: Europe OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 36: Europe OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 37: France OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 38: France OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 39: France OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 40: France OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 41: France OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 42: Germany OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 43: Germany OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 44: Germany OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 45: Germany OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 46: Germany OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 47: Italy OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 48: Italy OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 49: Italy OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 50: Italy OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 51: Italy OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 52: Spain OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 53: Spain OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 54: Spain OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 55: Spain OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 56: Spain OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 57: United Kingdom OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 58: United Kingdom OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 59: United Kingdom OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 60: United Kingdom OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 61: United Kingdom OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 62: Asia-Pacific OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 63: Asia-Pacific OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 64: Asia-Pacific OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 65: Asia-Pacific OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 66: Asia-Pacific OTC Drugs Market Size, By Country (USD Million), 2015-2025F
  • Figure 67: Asia-Pacific OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 68: Asia-Pacific OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 69: China OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 70: China OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 71: China OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 72: China OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 73: China OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 74: India OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 75: India OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 76: India OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 77: India OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 78: India OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 79: Japan OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 80: Japan OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 81: Japan OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 82: Japan OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 83: Japan OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 84: South Korea OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 85: South Korea OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 86: South Korea OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 87: South Korea OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 88: South Korea OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 89: Australia OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 90: Australia OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 91: Australia OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 92: Australia OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 93: Australia OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 94: Middle East and Africa OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 95: Middle East and Africa OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 96: Middle East and Africa OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 97: Middle East and Africa OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 98: Middle East and Africa OTC Drugs Market Size, By Country (USD Million), 2015-2025F
  • Figure 99: Middle East and Africa OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 100: Middle East and Africa OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 101: South Africa OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 102: South Africa OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 103: South Africa OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 104: South Africa OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 105: South Africa OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 106: Saudi Arabia OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 107: Saudi Arabia OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 108: Saudi Arabia OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 109: Saudi Arabia OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 110: Saudi Arabia OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 111: Kuwait OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 112: Kuwait OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 113: Kuwait OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 114: Kuwait OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 115: Kuwait OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 116: UAE OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 117: UAE OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 118: UAE OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 119: UAE OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 120: UAE OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 121: South America OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 122: South America OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 123: South America OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 124: South America OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 125: South America OTC Drugs Market Size, By Country (USD Million), 2015-2025F
  • Figure 126: South America OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 127: South America OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 128: Brazil OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 129: Brazil OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 130: Brazil OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 131: Brazil OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 132: Brazil OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 133: Argentina OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 134: Argentina OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 135: Argentina OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 136: Argentina OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 137: Argentina OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 138: Colombia OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 139: Colombia OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 140: Colombia OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 141: Colombia OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 142: Colombia OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
目次
Product Code: 5054

Title:
Global Over the Counter (OTC) Drugs Market, By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements (VMS), Other), By Dosage Form (Tablets, Capsules, Powders, Ointments, Liquids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other), By Region, Forecast & Opportunities, 2025.

Global Over the Counter (OTC) drugs market exceeded USD 140 billion in 2019 and is expected to grow at a CAGR of around 8.23% during the forecast period. The global OTC drugs market is driven by rising health consciousness among the population across the globe. Moreover, buying OTC drugs is cost effective as they need no prescription, which is expected to positively impact the growth of market during the forecast period. The availability and affordability of these medicines has further increased the adoption rates of the OTC drugs in the market. Also, rapidly expanding healthcare and pharmaceuticals industries, is further expected to bolster the growth of market over the next few years.

The global over the counter (OTC) drugs market is segmented based on product, dosage form, distribution channel, company, and region. Based on product, the market can be categorized into cough, cold and flu products, analgesics, dermatology products, vitamins, mineral and supplements (VMS) and other. Out of these, the cough, cold, and flu products segment dominated the market in terms of largest market share until 2019 and is expected to maintain its leading position the market during the forecast period as well. This can be ascribed to growing number of infections which is leading to the rise in the number of infectious diseases. The market is further driven by the increasing efforts to licencing of OTC drugs for the treatment of cough, cold and flu. In addition to this, vitamins, mineral, and supplements (VMS) segment is expected to grow at a high pace in the next 5 years on account of the rising popularity of VMS products in developed countries because of the increasing diseased population. Based on the dosage form, the market is segmented into tablets, capsules, ointments, liquids, and powders. Out of these, tablets segment dominates the market and is expected to maintain its position. Tablets are usually preferred by the doctors and patients as it is the most convenient oral dosage form. Based on the distribution channel, the market can be segmented into retail pharmacies, hospital pharmacies, online pharmacy, and others. Out of these, retail pharmacies segment is the leading segment as, these are easily accessible. Furthermore, retail pharmacies have availability of a variety of drugs.

Major players operating in the global over the counter (OTC) drugs market include Johnson and Johnson, GlaxoSmithKline PLC (GSK Consumer Healthcare), Perrigo Company PLC, Reckitt Benckiser Group PLC, Takeda Pharmaceutical Company Ltd, Roche Holding AG, The Procter & Gamble Company, Sanofi S.A, Gilead Sciences Inc., Bayer Healthcare AG, AstraZeneca plc., Alacer Corp., Alcon Inc., and others. The companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments in order to expand their geographic reach and to increase their customer bases.

Years considered for this report:

  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and estimate the market size of global over the counter (OTC) drugs market from 2015 to 2018.
  • To estimate and forecast the market size of global over the counter (OTC) drugs market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global over the counter (OTC) drugs market based on product, dosage form, distribution channel, company and regional distribution.
  • To identify dominant region or segment in the global over the counter (OTC) drugs market.
  • To identify drivers and challenges for global over the counter (OTC) drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global over the counter (OTC) drugs market.
  • To conduct pricing analysis for global over the counter (OTC) drugs market.
  • To identify and analyze the profile of leading players operating in global over the counter (OTC) drugs market.
  • To identify key sustainable strategies adopted by market players in global over the counter (OTC) drugs market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the products and presence of all major players across the globe.

TechSci Research calculated the market size of global over the counter (OTC) drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Over the counter (OTC) drugs manufacturers, suppliers and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to over the counter (OTC) drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global over the counter (OTC) drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Over the Counter (OTC) Drugs Market, By Product:

Cough, Cold, and Flu, Analgesics

Dermatology Products

Vitamins, Mineral, and Supplements (VMS)

Other

  • Global Over the Counter (OTC) Drugs Market, By Dosage Form:

Tablets

Capsules

Powders

Ointments

Liquids

  • Global Over the Counter (OTC) Drugs Market, By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacy

Other

  • Global Over the Counter (OTC) Drugs Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global over the counter (OTC) drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Over the Counter (OTC) Drugs Market

4. Executive Summary

5. Voice of Customer

6. Global Over the Counter (OTC) Drugs Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements (VMS), Other)
    • 6.2.2. By Dosage Form (Tablets, Capsules, Powders, Ointments, Liquids)
    • 6.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other)
    • 6.2.4. By Company (2019)
    • 6.2.5. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Over the Counter (OTC) Drugs Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Dosage Form
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Over the Counter (OTC) Drugs Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Dosage Form
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. India Over the Counter (OTC) Drugs Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Dosage Form
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. Australia Over the Counter (OTC) Drugs Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Dosage Form
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Japan Over the Counter (OTC) Drugs Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Dosage Form
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. South Korea Over the Counter (OTC) Drugs Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Dosage Form
        • 7.3.5.2.3. By Distribution Channel

8. Europe Over the Counter (OTC) Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Dosage Form
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Over the Counter (OTC) Drugs Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Dosage Form
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. Germany Over the Counter (OTC) Drugs Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Dosage Form
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. United Kingdom Over the Counter (OTC) Drugs Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Dosage Form
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. Italy Over the Counter (OTC) Drugs Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Dosage Form
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Spain Over the Counter (OTC) Drugs Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Dosage Form
        • 8.3.5.2.3. By Distribution Channel

9. North America Over the Counter (OTC) Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Dosage Form
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Over the Counter (OTC) Drugs Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Dosage Form
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Mexico Over the Counter (OTC) Drugs Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Dosage Form
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. Canada Over the Counter (OTC) Drugs Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Dosage Form
        • 9.3.3.2.3. By Distribution Channel

10. South America Over the Counter (OTC) Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Dosage Form
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Over the Counter (OTC) Drugs Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Dosage Form
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Argentina Over the Counter (OTC) Drugs Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Dosage Form
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Colombia Over the Counter (OTC) Drugs Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Dosage Form
        • 10.3.3.2.3. By Distribution Channel

11. Middle East and Africa Over the Counter (OTC) Drugs Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Dosage Form
    • 11.2.3. By Distribution Channel
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Over the Counter (OTC) Drugs Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Dosage Form
        • 11.3.1.2.3. By Distribution Channel
    • 11.3.2. Saudi Arabia Over the Counter (OTC) Drugs Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Dosage Form
        • 11.3.2.2.3. By Distribution Channel
    • 11.3.3. UAE Over the Counter (OTC) Drugs Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Dosage Form
        • 11.3.3.2.3. By Distribution Channel
    • 11.3.4. Kuwait Over the Counter (OTC) Drugs Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product
        • 11.3.4.2.2. By Dosage Form
        • 11.3.4.2.3. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles
  • 14.3. Leading Players Profiled
    • 14.3.1. Johnson and Johnson
    • 14.3.2. GlaxoSmithKline PLC (GSK Consumer Healthcare)
    • 14.3.3. Perrigo Company PLC
    • 14.3.4. Reckitt Benckiser Group PLC
    • 14.3.5. Takeda Pharmaceutical Company Ltd
    • 14.3.6. Roche Holding AG
    • 14.3.7. The Procter & Gamble Company
    • 14.3.8. Sanofi S.A
    • 14.3.9. Gilead Sciences Inc.
    • 14.3.10. Bayer Healthcare AG
    • 14.3.11. AstraZeneca plc.
    • 14.3.12. Alacer Corp.
    • 14.3.13. Alcon Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.